Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02508259 · ClinicalTrials.gov registry record · Phase 1

University of California, San Diego (UCSD) Suramin Autism Treatment-1 (SAT1) Trial

A Phase 1 study of Autism Spectrum Disorders, sponsored by University of California, San Diego.

Completed
Registry status
Phase 1
Development phase
10
Enrollment target
1
Study location

NCT02508259 is a Phase 1 study of Autism Spectrum Disorders that has completed, run by University of California, San Diego. The registered enrollment target is 10 participants, below the 168-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02508259, a Phase 1 study of Autism Spectrum Disorders, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
Phase 1
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

This study is designed to test the safety and efficacy of a single, intravenous dose of suramin in autism spectrum disorders (ASD).

Conditions Studied

Autism Spectrum Disorders

Interventions

  • DRUG Saline
  • DRUG Suramin

Study Locations (1)

California

  • University of California, San Diego School of Medicine - La Jolla

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2015-05
Est. Completion 2016-04
Phase Phase 1

Sponsor

University of California, San Diego

775 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02508259

The ClinicalTrials.gov registry entry for NCT02508259 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 168-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (94% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorders appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.

NCT02508259 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02508259 about?

NCT02508259 is a clinical study titled "University of California, San Diego (UCSD) Suramin Autism Treatment-1 (SAT1) Trial". This study is designed to test the safety and efficacy of a single, intravenous dose of suramin in autism spectrum disorders (ASD).

What is the current status of trial NCT02508259?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2015-05. Estimated completion is 2016-04.

What conditions does trial NCT02508259 study?

This clinical trial studies the following conditions: Autism Spectrum Disorders.

What interventions are being tested in trial NCT02508259?

The interventions under investigation include: Saline (DRUG), Suramin (DRUG).

Who is sponsoring clinical trial NCT02508259?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02508259 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Autism Spectrum Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Autism Spectrum Disorders

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.